Protara Therapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
Business Address
345 PARK AVENUE SOUTH, NEW YORK, NY, 10010
Mailing Address
345 PARK AVENUE SOUTH, NEW YORK, NY, 10010
Phone
646-844-0337
Fiscal Year End
1231
EIN
204580525
Financial Overview
FY2025
$209.47M
Total Assets
$-1.34
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 9, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 10, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
| 4 Insider stock transaction report | January 27, 2026 | View on SEC |
Annual Reports
10-K
March 10, 2026
- Advancing two promising drug candidates, TARA-002 (NMIBC, LMs) and IV Choline Chloride (IFALD), with TARA-002's registrational trial enrollment expected in H2 2026.
- Positive interim results for TARA-002 in NMIBC (Feb 2026) and positive FDA feedback on its registrational trial design.
Insider Trading
SELL
1 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Relay Therapeutics, Inc.
RLAY
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
COMPUGEN LTD
CGEN
Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc.
PCVX
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.